InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,539.03
(
1.22%
)
Post# of 120
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

@LaughinPaulRyan

Send PM Follow Ignore
Followers 65
Posts 4647
Boards Moderated 0
Alias Born 02/12/2013

@LaughinPaulRyan

Re: None

Friday, 11/06/2020 9:12:55 AM

Friday, November 06, 2020 9:12:55 AM

Post# of 120
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company has changed its official name to Neuropathix, Inc. (“Neuropathix”) with a new ticker symbol (OTCQB: NPTX).

“As the Company looks to expand on our biopharmaceutical research, the name Neuropathix better showcases our commitment to successfully moving our non-opioid cannabinoid-inspired leading compounds, including KLS-13019, into clinical trials,” said Dean Petkanas, CEO of Neuropathix.

@LaughinPaulRyan - WSJ, High Times, Main Street, Yahoo!



Offering EXTREMELY valuable info and speculation without Explanation.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up